Elevated vascular endothelia growth factor-A in the serum and peritoneal fluid of patients with endometriosis

Abstract

There has been emergence of evidence suggesting that specific variants of the vascular endothelia growth factor (VEGF) family, based on their ability to regulate angiogenesis, would be pivotal in the pathogenesis of endometriosis. This study was aimed at determining whether high levels of VEGF-A could be found in the serum and peritoneal fluid (PF) of patients with endometriosis. VEGF-A levels were measured by enzyme-linked immunosorbent assay (ELISA) in serum and PF from 46 patients with surgically confirmed endometriosis, and 40 controls with no clinical evidence of the disease or detectable endometriotic lesions at the time of surgical examination. The results showed the mean VEGF-A levels were significantly higher in the serum and PF of patients with endometriosis than in the controls. The VEGF-A levels in the serum and PF of patients with severe endometriosis (stages III–IV) were significantly higher than in those with minimal endometriosis (P<0.001). It was concluded that endometriosis was associated with significant modulation in the levels of circulating VEGF-A.

Keywords

vascular endothelial growth factor-A / endometriosis / peritoneal fluid / reproduction

References

[1] OzkanS., AriciA.. Advances in treatment options of endometriosis. Gynecol Obstet Invest, 2008, 67(2): 81-91

[2] TakeharaM., UedaM., YamashitaY., et al.. Vascular endothelial growth factor A and C gene expression in endometriosis. Hum Pathol, 2004, 35(11): 1369-1375

[3] GirlingJ.E., RogersP.A.. Recent advances in endometrial angiogenesis research. Angiogenesis, 2005, 8(2): 89-99

[4] ChoS.H., OhY.J., NamA., et al.. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. Am J Reprod Immunol, 2007, 58(6): 497-504

[5] García-ManeroM., AlcazarJ.L., ToledoG.. Vascular endothelial growth factor (VEGF) and ovarian endometriosis: correlation between VEGF serum levels, VEGF cellular expression, and pelvic pain. Fertil Steril, 2007, 88(2): 513-515

[6] Pupo-NogueiraA., de OliveiraR.M., PettaC.A., et al.. Vascular endothelial growth factor concentrations in the serum and peritoneal fluid of women with endometriosis. Int J Gynaecol Obstet, 2007, 99(1): 33-37

[7] FerreroS., GillottD.J., AnseriniP., et al.. Methodological concerns regarding levels of vascular endothelial growth factor (VEGF) in serum of patients with endometriosis. Hum Reprod, 2004, 19(1): 220-221

[8] McLarenJ., PrenticeA., Charnock-JonesD.S., et al.. Vascular endothelial growth factor is produced by PF macrophages in endometriosis and is regulated by ovarian ster oids. J Clin Invest, 1996, 98(2): 482-489

[9] TorryD.S., HoltV.J., KeenanJ.A., et al.. Vascular endothelial growth factor expression in cycling human endometrium. Fertil Steril, 1996, 66(1): 72-80

[10] DornC., ReinsbergJ., KupkaM., et al.. Leptin, VEGF, IGF-1, and IGFBP-3 concentrations in serum and follicular fluid of women undergoing in vitro fertilization. Arch Gynecol Obstet, 2003, 268(3): 187-193

[11] XavierP., BeloL., BeiresJ., et al.. Serum levels of VEGF and TNF-alpha and their association with C-reactive protein in patients with endometriosis. Arch Gynecol Obstet, 2006, 273(4): 227-231

[12] DonnezJ., SmoesP., GillerotS., et al.. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod, 1998, 13(6): 1686-1690

[13] KaluE., SumarN., GiannopoulosT., et al.. Cytokine profiles in serum and PF from infertile women with and without endometriosis. J Obstet Gynaecol Res, 2007, 33(4): 490-495

[14] FujishitaA., HasuoA., KhanK.N., et al.. Immunohistochemical study of angiogenic factors in endometrium and endometriosis. Gynecol Obstet Invest, 1999, 48(Suppl1): 36-44

[15] McLarenJ., PrenticeA., Charnock-JonesD.S., et al.. Vascular endothelial growth factor (VEGF) concentrations are elevated in PF of women with endometriosis. Hum Reprod, 1996, 11(1): 220-223

[16] AttarE., GencS., BulgurcuogluS., et al.. Increased concentration of vascular endothelial growth factor in the follicular fluid of patients with endometriosis does not affect the outcome of in vitro fertilization-embryo transfer. Fertil Steril, 2003, 80(6): 1518-1520

[17] BreenE.C.. VEGF in biological control. J Cell Biochem, 2007, 102(6): 1358-1367

[18] OtrockZ.K., MakaremJ.A., ShamseddineA.I.. Vascular endothelial growth factor family of ligands and receptors: review. Blood Cells Mol Dis, 2007, 38(3): 258-268

[19] KanoM.R., MorishitaY., IwataC., et al.. VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling. J Cell Sci, 2005, 118(Pt16): 3759-3768

[20] BourlevV., VolkovN., PavlovitchS., et al.. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions. Reproduction, 2006, 132(3): 501-509

[21] McLarenJ., PrenticeA., Charnock-JonesD.S., et al.. Vascular endothelial growth factor is produced by PF macrophages in endometriosis and is regulated by ovarian steroids. J Clin Invest, 1996, 98(2): 482-489

[22] LinY.J., LaiM.D., LeiH.Y., et al.. Neutrophils and macrophages promote angiogenesis in the early stage of endometriosis in a mouse model. Endocrinology, 2006, 147(3): 1278-1286

[23] BeckerC.M., D’AmatoR.J.. Angiogenesis and antiangiogenic therapy in endometriosis. Microvasc Res, 2007, 74(2–3): 121-130

[24] TeeM.K., VigneJ.L., TaylorR.N.. All-trans retinoic acid inhibits vascular endothelial growth factor expression in a cell model of neutrophil activation. Endocrinology, 2006, 147(3): 1264-1270